Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

The University of British Columbia

$25,000.00

Selection and Detection: Engineering Implantable Biosensors for Real-Time Brain Monitoring

EF 2024-25

Résumé
The aim of the Hariri Lab research is to develop a new type of biosensor that can detect multiple neurochemicals simultaneously in real time in complex matrices. This advanced interdisciplinary research program, combining expertise from Canada and the US, explores the marriage of aptamer switches technology with miniaturized waveguides and optoelectronics to generate highly sensitive and specific biosensors for applications in neuroscience. If successful, this technology could provide a real-time "movie" of how different neurochemicals influence brain circuits, leading to a greater understanding of the effects of drugs on brain function and the underlying causes of brain disorders. The knowledge generated by such sensors could ultimately lead to the development of new therapeutic agents and better care and treatment options for Canadians with neurological disorders, while also reducing the burden on the healthcare system. In addition to its potential use for NMs detection, such platform could also be applied to a wide range of biomedical applications, for the detection of other biomarkers, for the early-stage diagnosis of high mortality rate diseases in Canada such as Cancer, Sepsis, Diabetes among others. Through this program, trainees including undergraduate, graduate and postdoctoral scholars will gain valuable skills with areas of expertise ranging from chemistry, chemical biology to electrical and biomedical engineering opening a wide range of research and job opportunities. This will contribute to maintaining Canada's leading position in biotechnology and diagnostics to solve key biomedical problems.
Programme
Alliance Grants
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
597405-2024
Name nom
Hariri, Amani A
Department département
Chemistry
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Selection and Detection: Engineering Implantable Biosensors for Real-Time Brain Monitoring
Keywords
aptamer selection; brain interfaces; dna nanomaterials; integrated biosensors; miniaturized bioelectronics; molecular engineering; molecular switches; optical waveguides; real-time detection; single molecule diagnostics
Application summary
The aim of the Hariri Lab research is to develop a new type of biosensor that can detect multiple neurochemicals simultaneously in real time in complex matrices. This advanced interdisciplinary research program, combining expertise from Canada and the US, explores the marriage of aptamer switches technology with miniaturized waveguides and optoelectronics to generate highly sensitive and specific biosensors for applications in neuroscience. If successful, this technology could provide a real-time "movie" of how different neurochemicals influence brain circuits, leading to a greater understanding of the effects of drugs on brain function and the underlying causes of brain disorders. The knowledge generated by such sensors could ultimately lead to the development of new therapeutic agents and better care and treatment options for Canadians with neurological disorders, while also reducing the burden on the healthcare system. In addition to its potential use for NMs detection, such platform could also be applied to a wide range of biomedical applications, for the detection of other biomarkers, for the early-stage diagnosis of high mortality rate diseases in Canada such as Cancer, Sepsis, Diabetes among others. Through this program, trainees including undergraduate, graduate and postdoctoral scholars will gain valuable skills with areas of expertise ranging from chemistry, chemical biology to electrical and biomedical engineering opening a wide range of research and job opportunities. This will contribute to maintaining Canada's leading position in biotechnology and diagnostics to solve key biomedical problems.